Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports pharmacokinetics and pharmacodynamics data for IPX054 in subjects with idiopathic Parkinson's disease from Phase 1 and Phase 2 s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Parkinson Disease

Drugs mentioned

• IPX054 (IPX054)

Snippet

Sponsor: Impax Laboratories, LLC | Conditions: Idiopathic Parkinson's Disease | Phase 1, Phase 2 | Status: COMPLETED